Brian Fiske

ORCID: 0000-0002-8797-2042

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop”.

GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop

Journal of Parkinson's Disease(2020)10.3233/jpd-202004

N/A

3.5DataRank · unranked

135 citations

Anders Björklund, Don M. Gash, Alan Whone, Amber Van Laar, Jeffrey H. Kordower +26 more

The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants

Neurobiology of Aging(2014)10.1016/j.neurobiolaging.2013.07.013

N/A

1.6DataRank · unranked

41 citations

Alexis Elbaz, Daniel J. Serie, Grazia Annesi, Georg Auburger, Justin A. Bacon +55 more

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

Nature Genetics(2014)10.1038/ng.3043

N/A

1.1DataRank · unranked

1956 citations

NeuroGenetics Research Consortium (NGRC), The Ashkenazi Jewish Dataset Investigator, Cohorts for Health and Aging Research in Genetic Epidemiology (CHARGE), Alzheimer Genetic Analysis Group, Nathan Pankratz +49 more

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study

The Lancet Neurology(2011)10.1016/s1474-4422(11)70175-2

N/A

0.876DataRank · unranked

343 citations

Michael G. Heckman, Nadine Abahuni, Grazia Annesi, Justin A. Bacon, Soraya Bardien +60 more

The Parkinson's Disease Genome‐Wide Association Study Locus Browser

Movement Disorders(2020)10.1002/mds.28197

N/A

0.698DataRank · unranked

104 citations

Jonggeol J. Kim, Mary B. Makarious, Hirotaka Iwaki, Anastasia Illarionova, Kajsa Brolin +20 more

Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium

Movement Disorders(2013)10.1002/mds.25600

N/A

0.538DataRank · unranked

35 citations

Alexandra I. Soto‐Ortolaza, Nadine Abahuni, Grazia Annesi, Justin A. Bacon, Soraya Bardien +65 more

Seeking progress in disease modification in Parkinson disease

Parkinsonism & Related Disorders(2021)10.1016/j.parkreldis.2021.09.006

N/A

0.416DataRank · unranked

15 citations

Jesse M. Cedarbaum, Ted M. Dawson, E. Ray Dorsey, Carlos Alberto Faraco, Howard J. Federoff +18 more

Genome-wide association studies of LRRK2 modifiers of Parkinson's disease

medRxiv(2020)10.1101/2020.12.14.20224378

N/A

0.360DataRank · unranked

10 citations

Babak Alipanahi, Pierre Fontanillas, Tae‐Hwi Schwantes‐An, Jan Aasly, Roy N. Alcalay +55 more

Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease

Annals of Neurology(2021)10.1002/ana.26094

N/A

0DataRank · unranked

50 citations

Babak Alipanahi, Pierre Fontanillas, Tae‐Hwi Schwantes‐An, Jan Aasly, Roy N. Alcalay +56 more

Neurotrophic factors for Parkinson's disease: Current status, progress, and remaining questions. Conclusions from a 2023 workshop

Journal of Parkinson s Disease(2024)10.1177/1877718x241301041

N/A

0DataRank · unranked

13 citations

Märt Saarma, Clive N. Svendsen, Catherine Morgan, Alan Whone, Massimo S. Fiandaca +14 more